In Vivo CRO Market Trends

In Vivo CRO Market Trends

• Increasing demand for personalized medicine is expected to drive the demand for in vivo CRO services.
   
• Personalized medicine requires a deep understanding of the patient's genetic makeup, lifestyle, and environment to develop targeted therapies. In vivo CRO services play a crucial role in this process by providing expertise in preclinical research, including animal studies to evaluate the safety and efficacy of new drugs and treatments.
   
• Additionally, personalized medicine often involves complex research methodologies, including genetically modified animal models and specialized disease models. Moreover, personalized therapies require rigorous testing and validation to meet regulatory standards. In vivo CROs with experience in navigating regulatory pathways and ensuring compliance are essential for advancing personalized medicine therapies.
   
• In 2023, FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Thus, as personalized medicine continues to advance, the need for specialized CRO services that can conduct complex in vivo studies is expected to increase, driving growth in the in vivo CRO industry.